Ethical considerations when co-analyzing ancient DNA and data from private genetic databases.


Journal

American journal of human genetics
ISSN: 1537-6605
Titre abrégé: Am J Hum Genet
Pays: United States
ID NLM: 0370475

Informations de publication

Date de publication:
07 09 2023
Historique:
received: 13 04 2023
revised: 15 06 2023
accepted: 21 06 2023
medline: 11 9 2023
pubmed: 5 8 2023
entrez: 4 8 2023
Statut: ppublish

Résumé

Ancient DNA studies have begun to explore the possibility of identifying identical DNA segments shared between historical and living people. This research requires access to large genetic datasets to maximize the likelihood of identifying previously unknown, close genetic connections. Direct-to-consumer genetic testing companies, such as 23andMe, Inc., manage by far the largest and most diverse genetic databases that can be used for this purpose. It is therefore important to think carefully about guidelines for carrying out collaborations between researchers and such companies. Such collaborations require consideration of ethical issues, including policies for sharing ancient DNA datasets, and ensuring reproducibility of research findings when access to privately controlled genetic datasets is limited. At the same time, they introduce unique possibilities for returning results to the research participants whose data are analyzed, including those who are identified as close genetic relatives of historical individuals, thereby enabling ancient DNA research to contribute to the restoration of information about ancestral connections that were lost over time, which can be particularly meaningful for families and groups where such history has not been well documented. We explore these issues by describing our experience designing and carrying out a study searching for genetic connections between 18th- and 19th-century enslaved and free African Americans who labored at Catoctin Furnace, Maryland, and 23andMe research participants. We share our experience in the hope of helping future researchers navigate similar ethical considerations, recognizing that our perspective is part of a larger conversation about best ethical practices.

Identifiants

pubmed: 37541241
pii: S0002-9297(23)00212-4
doi: 10.1016/j.ajhg.2023.06.011
pmc: PMC10502734
mid: NIHMS1921189
pii:
doi:

Substances chimiques

DNA, Ancient 0
DNA 9007-49-2

Types de publication

Journal Article Review Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1447-1453

Subventions

Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM100233
Pays : United States

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests E.H., S.M., and S.A.E. are employees and shareholders of 23andMe, Inc. During the summer of 2021, R.C. was employed as an intern at 23andMe, Inc.

Références

Nat Rev Genet. 2020 Jun;21(6):377-384
pubmed: 32251390
Am J Biol Anthropol. 2023 Jun;181(2):163-165
pubmed: 36790590
Eur Urol Open Sci. 2022 Sep 17;45:23-30
pubmed: 36353656
Commun Biol. 2021 Nov 5;4(1):1269
pubmed: 34741098
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
J Pathol. 2021 Jul;254(4):418-429
pubmed: 33748968
Sci Adv. 2021 Oct 29;7(44):eabh2013
pubmed: 34705496
Nat Commun. 2018 Jul 27;9(1):2957
pubmed: 30054469
Am J Hum Genet. 2020 Aug 6;107(2):265-277
pubmed: 32707084
Curr Opin Genet Dev. 2020 Jun;62:91-96
pubmed: 32721847
Nat Rev Genet. 2020 Nov;21(11):645-647
pubmed: 32939074
PLoS One. 2015 Mar 23;10(3):e0121409
pubmed: 25799293
Am J Hum Genet. 2021 Nov 4;108(11):2052-2070
pubmed: 34739834
Am J Hum Genet. 2020 Aug 6;107(2):183-195
pubmed: 32763189
Proc Natl Acad Sci U S A. 2011 Mar 29;108(13):5154-62
pubmed: 21383195
Mol Biol Evol. 2021 May 4;38(5):2131-2151
pubmed: 33355662
Science. 2018 Apr 27;360(6387):384-385
pubmed: 29700256
Science. 2023 Aug 4;381(6657):eade4995
pubmed: 37535739
Proc Natl Acad Sci U S A. 2022 Mar 29;119(13):e2111533119
pubmed: 35312358
Am J Hum Genet. 2015 Jan 8;96(1):37-53
pubmed: 25529636
Science. 2021 Sep 24;373(6562):1449
pubmed: 34554792
Proc Natl Acad Sci U S A. 2023 Jan 17;120(3):e2201620120
pubmed: 36623185
Nat Rev Genet. 2009 May;10(5):331-5
pubmed: 19308065
Soc Stud Sci. 2008 Oct;38(5):759-83
pubmed: 19227820
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
HGG Adv. 2023 Jan 11;4(2):100161
pubmed: 37101579
Nature. 2021 Nov;599(7883):41-46
pubmed: 34671160
Am J Hum Genet. 2019 Jul 3;105(1):122-131
pubmed: 31204012
Curr Biol. 2023 Apr 24;33(8):1431-1447.e22
pubmed: 36958333
Proc Natl Acad Sci U S A. 2019 Jan 29;116(5):1471-1474
pubmed: 30696775
Per Med. 2016 Nov;13(6):563-574
pubmed: 29754546

Auteurs

Éadaoin Harney (É)

23andMe, Inc., Sunnyvale, CA 94043, USA; Department of Human Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA. Electronic address: eadaoinh@23andme.com.

Kendra Sirak (K)

Department of Human Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

Jakob Sedig (J)

Department of Human Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.

Steven Micheletti (S)

23andMe, Inc., Sunnyvale, CA 94043, USA.

Roslyn Curry (R)

23andMe, Inc., Sunnyvale, CA 94043, USA; Department of Human Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA.

Samantha Ancona Esselmann (S)

23andMe, Inc., Sunnyvale, CA 94043, USA.

David Reich (D)

Department of Human Evolutionary Biology, Harvard University, Cambridge, MA 02138, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA; Howard Hughes Medical Institute, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH